Characterization of receptor subtypes involved in prostanoid-induced conjunctival pruritus and their role in mediating allergic conjunctival itching

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 137-142

  Woodward, David F ^a   Nieves, Amelia L ^a   Friedlaender, Mitchell H ^b  

^a ALLERGAN INC   (United States)

^b SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 [4 (1 HYDROXYHEXYL)PHENYL] 5 OXOCYCLOPENTANEHEPTANOIC ACID; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ARACHIDONIC ACID; CARBACYCLIN; FLUPROSTENOL; GR 63799X; HISTAMINE; KETOROLAC TROMETAMOL; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN J2; PROSTANOID; RECEPTOR SUBTYPE; THROMBOXANE A2; UNCLASSIFIED DRUG;

ALLERGIC CONJUNCTIVITIS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROVOCATION TEST; PRURITUS; SCRATCHING; TOPICAL DRUG ADMINISTRATION;

ANIMALS; CONJUNCTIVITIS, ALLERGIC; FEMALE; GUINEA PIGS; KETOROLAC; MALE; PROSTAGLANDINS; PRURITUS; RECEPTORS, PROSTAGLANDIN; TOLMETIN;

EID: 0030432377     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ABELSON, M. B. AND ALLANSMITH, M. R: Histamine and the eye. In Immunology and Immunopathology of the Eye, ed. by M. S. Silverstein and C. R. O'Connor, pp. 362-364, Masson, New York, 1979.
2. 2 in allergic ocular disease. In Advances in Immunology and Immunopathology of the Eye, ed. by G. R. O'Connor and J. W. Chandler, pp. 163-166, Year Book Medical Publishers Inc., Chicago, 1985.
3. AICHAME, A., CAMPBELL, A. M., CHANAL, I., RICHARD, M. C., ARNEWD, B., MICHEL, F-B. AND BOUSQUET, J: Precision of conjunctival provocation tests in right and left eyes. J. Allergy Clin. Immunol. 92: 49-55, 1993.
4. ARMSTRONG, R. A., LAWRENCE, R. A., JONES, R. L., WILSON, N. H. AND COLLIER, A. H: Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors. Br. J. Pharmacol. 97: 657-668, 1989.
5. BALLAS, Z., BLUMENTHAL, M., TINKELMAN, D. G., KRIZ, R. AND RUPP, R: Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis. Surv. Ophthalmol. 38: 141-148, 1993.
6. BUCKLEY, M. M. AND BROGDEN, R. N: Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 39: 86-109, 1990.
7. 3 receptors. In Advances in Prostaglandin, Thromboxane, and Leukotriene Research, ed. by B. Samuelsson, P. W. Ramwell, R. Paoletti, G. Folco and E. Granström, vol. 21, pp. 379-382, New York, Raven Press, 1990.
8. 2α-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients. Ophthalmology 96: 1329-1337, 1989.
9. 2α metabolism by human ocular tissues. Invest. Ophthalmol. Vis. Sci. 31: 1389-1393, 1990.
10. COLEMAN, R. A., HUMPHREY, P. P. A. AND KENNEDY I: Prostanoid receptors in smooth muscle: Further evidence for a proposed classification. Trends Autonom. Pharmacol. 3: 35-49, 1982.
11. COLEMAN, R. A., HUMPHREY, P. P. A., KENNEDY, I. AND LUMLEY, P: Prostanoid receptors: The development of a working classification. Trends Pharmacol. Sci. 5: 302-306, 1984.
12. COLEMAN, R. A., SMITH, W. L. AND NARUMIYA, S: Classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229, 1994.
13. DENMAN, S. T: A review of pruritus. J. Am. Acad. Dermatol. 14: 375-392, 1986.
14. GILES, H. P., LEFF, P., BOLOFO, M. L., KELLY, M. G. AND ROBERTSON, A. D: The classification of DP receptors in platelets and vasculature using BW A868C, a novel, selective, and potent competitive antagonist. Br. J. Pharmacol. 96: 291-300, 1989.
15. 2α in the human eye. Graefe's Arch. Clin. Exp. Ophthalmol. 222: 139-141, 1985.
16. 2 and a prostaglandin endoperoxide analog. J. Invest. Dermatol. 69: 327-330, 1977.
17. HELLEBOID, L., KHATAMI, M., WEI, Z-G. AND ROCKEY, J. H: Histamine and Prostacyclin. Primary and secondary release in allergic conjunctivitis. Invest. Ophthalmol. Vis. Sci. 32: 2281-2289, 1991.
18. 1 antihistamine chlorpheniramine maleate on histamine induced symptoms in the human conjunctiva. Allergy 37: 203-208, 1982.
19. KULKARNI, P. S., FLEISHER, L. AND SRINIVASAN, B. D: The synthesis of cyclooxygenase products in ocular tissues of various species. Curr. Eye Res. 3: 447-452, 1984.
20. KULKARNI, P. S., KAUFMAN, P. L. AND SRINIVASAN, B. D: Cyclooxygenase and lipoxygenase pathways in cynomolgus and rhesus monkey conjunctiva, anterior uvea and eyelids. Curr. Eye Res. 6: 801-808, 1987.
21. LAWRENCE, R. A. AND JONES, R. L: Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein. Br. J. Pharmacol. 63: 1339-1346, 1992.
22. 2 and it's analogue, BW 245C, on intraocular pressure in humans. Graefe's Arch. Clin. Exp. Ophthalmol. 229: 411-413, 1991.
23. 2-receptor agonist. Cardiovasc. Drug Rev. 11: 165-179, 1993.
24. PROUD, D., SWEET, J., STEIN, P., SETTIPANE, R. A., KAGEY-SOBOTKA, A., FREIDLAENDER, M. H. AND LICHTENSTEIN, L. M: Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J. Allergy Clin. Immunol. 85: 896-905, 1990.
25. TINKELMAN, D. G., RUPP, G., KAUFMAN, H., PUGELY, J. AND SCHULTZ, N: Double-masked, paired comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eye drops in the treatment of seasonal allergic conjunctivitis. Surv. Ophthalmol. 38: 133-140, 1993.
26. WAHLGREN, C-F: Pathophysiology of itching in urticaria and atopic dermatitis. Allergy 147: 65-75, 1992.
27. WOODWARD, D. F., CONWAY, J. L. AND WHEELER, L. A: Cutaneous itching models. In Models of Dermatology, ed. by H. J. Maibach and N. J. Lowe, vol. 1, pp. 187-195, Karger, Basel, 1985.
28. 2. Invest. Ophthalmol. Vis. Sci. 31: 138-146, 1990a.
29. 2 receptor. J. Ocul. Pharmacol. 11: 447-454, 1995b.
30. WOODWARD, D. F., LAWRENCE, R. A., FAIRBAIRN, C. E., SHAN, T. AND WILLIAMS, L. S: Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies. J. Lipid Med. 6: 545-553, 1993b.
31. WOODWARD, D. F., WASSERMAN, M. A. AND WEICHMAN, B. M: Investigation of leukotriene involvement in the vasopermeability response associated with guinea pig tracheal anaphylaxis: Comparison with cutaneous anaphylaxis. Eur. J. Pharmacol. 93: 9-16, 1989.
32. 2-mimetics are potent microvascular permeability factors in the conjunctiva. J. Pharmacol. Exp. Ther. 255: 23-27, 1990b.
33. WOODWARD, D. F., NIEVES, A. L., WILLIAMS, L. S. AND TUCKETT, R. P: Characterization of a behavioral model for peripherally evoked itch suggests platelet activating factor as a potent pruritogen. J. Pharmacol. Exp. Ther. 272: 758-765, 1995a.
34. WOODWARD, D. F., SPADA C. S., HAWLEY S. B., WILLIAMS L. S., PROTZMAN C. E. AND NIEVES, A. L: Further studies on ocular responses to DP receptor stimulation. Eur. J. Pharmacol. 230: 327-333, 1993a.